BeStock  
Stocks › Biotechnology › AVBP

ArriVent BioPharma AVBP

US equityMarket cap rank #3544Biotechnology
$10.52 −$0.74 (-6.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.52 0.00%
Open$11.00
Prev close$11.26
Day range$10.38 – $11.35
Volume1.05M
Market cap$544.13M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$48.38M-26.3% YoY
Net profit-$45.31M-29.5% YoY
Diluted EPS-$0.81+2.4% YoY
Free cash flow-$40.71M-13.7% YoY
Operating cash flow-$40.71M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-20.6MDec '24$-64.4MMar '25$-31.4MJun '25$-35.0MSep '25$-35.5MDec '25$-43.3MMar '26$-49.9MJun '26$-45.3MSep '26

Diluted EPS by quarter

-0.61Dec '24-1.90Mar '25-0.90Jun '25-0.83Sep '25-0.78Dec '25-0.96Mar '26-1.05Jun '26-0.81Sep '26

Free cash flow by quarter

$-16.2MDec '24$-68.0MMar '25$-26.1MJun '25$-35.8MSep '25$-30.7MDec '25$-41.9MMar '26$-39.6MJun '26$-40.7MSep '26

Annual revenue

$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-49.8%
Return on assets-46.8%
Return on invested capital-53.2%
Current ratio17.64
Liabilities / assets5.7%
Cash & investments$393.22M
Net cash (debt)$393.22M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $48.38M $52.69M $46.11M $177.53M $38.82M
Selling and Admin Expenses $9.48M $10.35M $8.49M $24.18M $6.65M
-General & Admin Expense $9.48M $10.35M $8.49M $24.18M $6.65M
Research & Development $38.90M $42.34M $37.62M $153.35M $32.18M
Operating Profit -$48.38M -$52.69M -$46.11M -$177.53M -$38.82M
Net Non-Operating Interest Income (Expense) $3.06M $2.80M $2.79M $11.23M $3.28M
Non-Operating Interest Income $3.06M $2.80M $2.79M $11.23M $3.28M
Pretax Profit -$45.31M -$49.89M -$43.32M -$166.31M -$35.54M
Net Profit -$45.31M -$49.89M -$43.32M -$166.31M -$35.54M
Profit from Continuing Operations -$45.31M -$49.89M -$43.32M -$166.31M -$35.54M
Net Income to Parent Company -$45.31M -$49.89M -$43.32M -$166.31M -$35.54M
Net Income to Common Stockholders -$45.31M -$49.89M -$43.32M -$166.31M -$35.54M
Basic EPS -$0.81 -$1.05 -$0.96 -$4.32 -$0.78
Diluted EPS -$0.81 -$1.05 -$0.96 -$4.32 -$0.78

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $417.09M $394.72M $349.30M $333.17M $333.17M
Total Current Assets $416.62M $394.17M $348.70M $332.90M $332.90M
Cash and Cash Equivalents & Short-Term Investments $393.22M $373.12M $326.38M $312.82M $312.82M
-Cash and Cash Equivalents $113.58M $154.68M $62.10M $45.54M $45.54M
-Short Term Investments $279.64M $218.44M $264.28M $267.28M $267.28M
Prepaid Assets $881,000.00 $1.15M $1.43M $186,000.00 $186,000.00
Other Current Assets $22.51M $19.91M $20.89M $19.83M $19.83M
Total Non-Current Assets $474,000.00 $545,000.00 $595,000.00 $272,000.00 $272,000.00
Net PPE $302,000.00 $370,000.00 $370,000.00 $13,000.00 $13,000.00
-Gross PPE $302,000.00 $370,000.00 $370,000.00 $13,000.00 $13,000.00
Non-Current Deferred Assets $38,000.00 $41,000.00 $69,000.00 $69,000.00 $69,000.00
Other Non-Current Assets $134,000.00 $134,000.00 $156,000.00 $190,000.00 $190,000.00
Total Liabilities $23.61M $27.88M $25.32M $25.95M $25.95M
Total Current Liabilities $23.61M $27.84M $25.00M $25.95M $25.95M
Payables $2.62M $2.22M $8.73M $5.93M $5.93M
-Accounts Payable $2.62M $2.22M $8.73M $5.93M $5.93M
Current Accrued Expenses $16.52M $21.64M $14.24M $13.45M $13.45M
Short-Term Debt and Capital Lease Obligation $256,000.00 $318,000.00 $99,000.00 $14,000.00 $14,000.00
-Current Capital Lease Obligation $256,000.00 $318,000.00 $99,000.00 $14,000.00 $14,000.00
Total Non-Current Liabilities $0.00 $33,000.00 $320,000.00 $0.00 $0.00
Total Equity $393.48M $366.84M $323.98M $307.22M $307.22M
Stockholders' Equity $393.48M $366.84M $323.98M $307.22M $307.22M
Capital Stock $5,000.00 $5,000.00 $5,000.00 $4,000.00 $4,000.00
-Common Stock $5,000.00 $5,000.00 $5,000.00 $4,000.00 $4,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $932.10M $864.96M $772.21M $711.85M $711.85M
Retained Earnings -$538.17M -$497.85M -$447.96M -$404.64M -$404.64M
Gains/Losses Not Affecting Retained Earnings -$466,000.00 -$267,000.00 -$270,000.00 $14,000.00 $14,000.00
Long Term Debt and Capital Lease Obligation – $33,000.00 $320,000.00 $0.00 $0.00
-Long Term Capital Lease Obligation – $33,000.00 $320,000.00 $0.00 $0.00
Receivables – – – $60,000.00 $60,000.00
-Taxes Receivable – – – $0.00 $0.00
-Other Receivables – – – $60,000.00 $60,000.00
Investments and Advances – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$40.71M -$39.58M -$41.89M -$160.59M -$30.66M
Net cash flow from continuing operations -$40.71M -$39.58M -$41.89M -$160.59M -$30.66M
Net Income from Continuing Operations -$40.31M -$49.89M -$43.32M -$166.31M -$35.54M
Other Non-Cash Items -$653,000.00 -$515,000.00 -$559,000.00 -$3.03M –
Change in Working Capital -$6.63M $4.16M -$3.50M -$3.77M $4.69M
-Change in Prepaid Assets -$2.44M $1.55M -$2.56M -$12.56M $275,000.00
-Change in Payables and Accrued Expense -$4.17M $2.63M -$1.02M $8.81M $4.42M
-Change in Other Current Assets $3,000.00 $47,000.00 $37,000.00 $0.00 $0.00
-Change in Other Current Liabilities -$28,000.00 -$67,000.00 $47,000.00 -$21,000.00 -$5,000.00
Net cash flow from investing -$60.65M $46.07M $3.58M -$71.23M -$71.20M
Net Cash Flow from Continuing Investing Activities -$60.65M $46.07M $3.58M -$71.23M -$71.20M
Net Investment Purchase and Sale -$60.65M $46.07M $3.58M -$71.23M -$71.20M
Financing Cash Flow $60.26M $86.09M $54.87M $203.06M $34.73M
Net Cash Flow from Continuing Financing Activities $60.26M $86.09M $54.87M $203.06M $34.73M
Net Common Stock Issuance $59.66M $85.24M $54.72M $202.63M $34.66M
Proceeds from Stock Option Exercised $606,000.00 $853,000.00 $149,000.00 $502,000.00 $84,000.00
Ending Cash Balance $113.58M $154.68M $62.10M $45.54M $45.54M
Net Change in Cash -$41.10M $92.58M $16.56M -$28.75M -$67.13M
Beginning Cash Balance $154.68M $62.10M $45.54M $74.29M $112.67M
Free Cash Flow -$40.71M -$39.58M -$41.89M -$160.59M -$30.66M
Net Other Financing Charges – – – -$70,000.00 -$17,000.00

Discussion

No comments yet — be the first to weigh in on AVBP.

Sign in to join the discussion.

Scroll to Top